IKARIA for IKARIA
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Budget/Appropriations BUD
Deficit reduction/impact of sequestration on FDA and NIH; FDA Safety Over Sequestration Act of 2015 (HR 1078); FDA, NIH, and BARDA/CDC appropriations.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANNE ELIZABETH ESPOSITO | — |
| LEAH DUFFY SVOBODA | — |
Copyright/Patent/Trademark CPT
STRONG Patents Act of 2015 (S632); The Innovation Act (HR9)
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANNE ELIZABETH ESPOSITO | — |
| LEAH DUFFY SVOBODA | — |
Health Issues HCR
340B Drug Pricing Program; Critical Care; 21st Century Cures initiative; Medical Device Tax Repeal (HR160/S149); Innovation for Healthier Americans Initiative
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANNE ELIZABETH ESPOSITO | — |
| LEAH DUFFY SVOBODA | — |
Medicare/Medicaid MMM
Non-interference; rebates; Protecting Seniors' Access to Medicare Act of 2015 (S/141 HR 1190)Medicare Access and Children's Health Insurance Plans Re-Authorization Act of 2015 (HR2)
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANNE ELIZABETH ESPOSITO | — |
| LEAH DUFFY SVOBODA | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.